Aegon Ltd announced sale of its UK operations to Standard Life for total consideration of £2.0 billion, comprising cash and shares.\\nThe deal includes a 15.3% stake in Standard Life (181.1 million shares) and £0.75 billion cash, valued at 14.2× 2025 earnings.\\nAegon will use cash for deleveraging and share buybacks, expects 5% annual operating result growth to €1.5 bn by 2027.\\nTransaction slated to close end‑2026, will cut solvency ratio by 5 pts, add €1.1 bn equity but reduce valuation equity by €0.1 bn.